CoChat

Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus

Grim, Shellee A., Rapp, Robert P., Martin, Craig A., Evans, Martin E. · 2005 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective. To review available data regarding the efficacy of trimethoprim‐sulfamethoxazole (TMP‐SMX) for the treatment of infections caused by methicillin‐resistant Staphylococcus aureus (MRSA). Data Sources. A MEDLINE search was performed (January 1966–December 2003) using the search terms Staphylococcus aureus , sulfamethoxazole, trimethoprim, co‐trimoxazole, and methicillin resistance. Abstracts from infectious diseases meetings also were reviewed. Data Synthesis. The reported rate of TMP‐SMX resistance in S. aureus is highly variable. From a mechanistic standpoint, TMP‐SMX resistance among MRSA appears to be distinct from multidrug resistance, although some anecdotal reports suggest otherwise. Clonal outbreaks of MRSA resistant to TMP‐SMX have been described; of these, the Brazilian clone has more often been resistant to TMP‐SMX than the Iberian clone. Rates of TMP‐SMX resistance are particularly high in institutions serving large numbers of patients infected by the human immunodeficiency virus, due to increased exposure for Pneumocystis prophylaxis. Limited studies and case reports have found TMP‐SMX useful against infections caused by MRSA. Conclusions. A large body of anecdotal data, but only one randomized clinical trial, indicates the effectiveness of TMP‐SMX as a treatment for MRSA infections. Double‐blind, randomized controlled trials are needed to compare the two available oral agents—TMP‐SMX and linezolid—against MRSA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.25.2.253.56956

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 94

Metadata

Authors
Grim, S. A., Rapp, R. P., Martin, C. A., & Evans, M. E.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2005-02
Volume
25
Issue
2
Pages
253-264
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2089180978
Cited by
94
References
4
FWCI
4.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus. https://app.cochat.ai/papers/10.1592/phco.25.2.253.56956
The paper
Grim, S. A., Rapp, R. P., Martin, C. A., & Evans, M. E. (2005). Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.25.2.253.56956

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.